Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide
Authors:
- 1 April 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 335 (8693) , 808-811
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1Nature, 1987
- Oligodeoxynucleotide stability in subcellular extracts and culture mediaJournal of Biochemical and Biophysical Methods, 1986
- Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteinsCell, 1985
- Myc/Ig juxtaposition by chromosomal translocations: some new insights, puzzles and paradoxesImmunology Today, 1985
- Identification of reciprocal translocation sites within the c-myc oncogene and immunoglobulin μ locus in a Burkitt lymphomaNature, 1983
- Translocations Among Antibody Genes in Human CancerScience, 1983
- Differential Expression of the Translocated and the Untranslocated c- myc Oncogene in Burkitt LymphomaScience, 1983
- Translocation and Rearrangements of the c- myc Oncogene Locus in Human Undifferentiated B-Cell LymphomasScience, 1983
- Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.Proceedings of the National Academy of Sciences, 1982
- Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.Proceedings of the National Academy of Sciences, 1982